Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
Authors
Keywords
Complement, Lectin pathway, MASP2, Coronavirus, COVID-19, Eculizumab
Journal
CLINICAL IMMUNOLOGY
Volume 219, Issue -, Pages 108555
Publisher
Elsevier BV
Online
2020-08-07
DOI
10.1016/j.clim.2020.108555

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.